[HTML][HTML] Learning curve for transbronchial lung cryobiopsy in diffuse lung disease
LM Almeida, B Lima, PC Mota, N Melo, A Magalhães… - Pulmonology, 2018 - Elsevier
Introduction Transbronchial lung cryobiopsy (TBLC) is increasingly used in the diagnosis of
diffuse lung disease (DLD), but no data have yet been published on the learning curve …
diffuse lung disease (DLD), but no data have yet been published on the learning curve …
Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival
PC Mota, ML Soares, CD Vasconcelos… - Journal of Molecular …, 2022 - Springer
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia
of unknown etiology. The role of genetic risk factors has been the focus of numerous studies …
of unknown etiology. The role of genetic risk factors has been the focus of numerous studies …
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
G Santos, A Fabiano, PC Mota, I Rodrigues… - Pulmonary …, 2023 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia
of unknown cause that is associated with radiological and/or histological features of usual …
of unknown cause that is associated with radiological and/or histological features of usual …
[HTML][HTML] Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
C Robalo-Cordeiro, P Campos, L Carvalho… - Revista Portuguesa de …, 2017 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that up to now has
been associated with a poor prognosis. However, the results of the INPULSIS and ASCEND …
been associated with a poor prognosis. However, the results of the INPULSIS and ASCEND …
[HTML][HTML] Heterozygous TERT gene mutation associated with familial idiopathic pulmonary fibrosis
SR Sousa, PC Mota, N Melo, HN Bastos… - … medicine case reports, 2019 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown cause
that occurs sporadically, but it can also occur in families and so named as Familial …
that occurs sporadically, but it can also occur in families and so named as Familial …
[HTML][HTML] Translating Idiopathic pulmonary fibrosis guidelines into clinical practice
C Robalo-Cordeiro, A Morais - Pulmonology, 2021 - Elsevier
Introduction and objectives Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive
fibrotic interstitial lung disease of unknown cause, which predominantly manifests in older …
fibrotic interstitial lung disease of unknown cause, which predominantly manifests in older …
Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
A Morais - Jornal Brasileiro de Pneumologia, 2019 - SciELO Brasil
Idiopathic pulmonary fibrosis (IPF) poses the greatest diagnostic challenge in the general
context of interstitial lung diseases and, in particular, regarding interstitial pneumonias.(1-4) …
context of interstitial lung diseases and, in particular, regarding interstitial pneumonias.(1-4) …
Impact of training on Malaysian respiratory physiotherapists' ability in detecting velcro crackles from pre-recorded lung sounds.
NA Azmi - 2022 - eprints.soton.ac.uk
Incidence of idiopathic pulmonary disease (IPF) is increasing worldwide and currently there
is no curative therapy for IPF. Velcro crackles are associated with IPF and could be detected …
is no curative therapy for IPF. Velcro crackles are associated with IPF and could be detected …
Idiopatinės plaučių fibrozės diagnostikos ir gydymo rekomendacijos 2017
K Malakauskas, K Biekšienė… - Pulmonologija ir …, 2017 - pia.pulmoalerg.lt
Idiopatinė plaučių fibrozė (IPF)–tai nežinomos priežasties lėtinės, progresuojančiai
fibrozuojančios intersticinės pneumonijos specifinė forma, išskirtinai pasireiškianti …
fibrozuojančios intersticinės pneumonijos specifinė forma, išskirtinai pasireiškianti …
Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis [Противоопухолевый …
I Mikhaylova, H Treshalina, I Shubina, I Manina… - 2021 - covid19.neicon.ru
В обзоре приведены данные литературы 2001–2020 гг., посвященные
патогенетическим и клиническим особенностям развития пневмофиброза …
патогенетическим и клиническим особенностям развития пневмофиброза …